Pei-Ru Jin

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Purdue University West Lafayette

Biochemistry, Genetics and Molecular BiologyEnvironmental SciencePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development”.

Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development

UNC Libraries(2020)10.17615/02e0-mp93

N/A

0DataRank · unranked

1 citations

Ling-Hsuan Chen, Anthony Y. Wu, Dongyu Gao, Tsaiyu Chiang, Chih-Chun Chang +12 more

Fusobacterium nucleatum produces previously unappreciated AHR-activating metabolites and promotes CRC cell proliferation via the AHR-TERT axis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.25.678601

N/A

0DataRank · unranked

2 citations

Pei-Ru Jin, Lydia H. Davis, Jimmy Orjala, Abigail T. Armstrong, Wen–Hung Wang +12 more